Skip to content

Clinical trials

Terminated Insulinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulinoma Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20091
20101
20142
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University2
Barts & The London NHS Trust1
ECOG-ACRIN Cancer Research Group1
Emory University1
Masonic Cancer Center, University of Minnesota1
National Cancer Institute (NCI)1
University of California, San Francisco1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulinoma9
Glucagonoma8
Somatostatinoma8
Carcinoma, Islet Cell7
Gastrinoma7
Adenoma, Islet Cell4
Neoplasms3
Vipoma3
Carcinoma, Medullary2
Carcinoma, Renal Cell2

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.